Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Oct 8;26(1):65.
doi: 10.1007/s11934-025-01291-3.

Evaluation and Management of Recurrent Pelvic Organ Prolapse

Affiliations
Review

Evaluation and Management of Recurrent Pelvic Organ Prolapse

Leslie M Rickey et al. Curr Urol Rep. .

Abstract

Purpose of review: Postoperative prolapse recurrence is not uncommon, despite advances in surgical options and techniques. There is no consensus on the optimal approach to guide counseling and management for patients with recurrent prolapse following surgical repair.

Recent findings: Risk factors for postoperative prolapse recurrence include patient factors, pelvic floor factors, and surgical approach. There are various definitions for prolapse recurrence, including anatomic measures and patient reported symptoms. The highest rate of prolapse recurrence is seen within two years of initial surgery. Retreatment for prolapse requires shared decision-making, considering the patient's symptomatology, anatomy, comorbidities, and long-term goals. There is limited data regarding the long-term success of reoperation for pelvic organ prolapse. Anatomic and patient factors that affect surgical re-treatment outcomes for recurrent prolapse are not well understood. Standardized definitions of prolapse recurrence and more long-term data are necessary to inform evidence-based treatment decisions.

Keywords: Pelvic Floor Disorders; Pelvic Floor Physical Therapy; Pessary; Recurrent Pelvic Organ Prolapse; Reoperation.

PubMed Disclaimer

Conflict of interest statement

Declarations. Human and Animal Rights: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines). Competing Interests: The authors declare no competing interests.

References

    1. Brown HW, Hegde A, Huebner M, Neels H, Barnes HC, Marquini GV et al. International urogynecology consultation Chap. 1 committee 2: epidemiology of pelvic organ prolapse: prevalence, incidence, natural history, and service needs. Int Urogynecol J. 2022:1–15.
    1. Dieter AA, Wilkins MF, Wu JM. Epidemiological trends and future care needs for pelvic floor disorders. Curr Opin Obstet Gynecol. 2015;27(5):380. - PubMed - PMC - DOI
    1. Wu JM, Hundley AF, Fulton RG, Myers ER. Forecasting the prevalence of pelvic floor disorders in US women: 2010 to 2050. Obstet Gynecol. 2009;114(6):1278–83. - PubMed - DOI
    1. Wiegersma M, Panman CM, Kollen BJ, Berger MY, Lisman-Van Leeuwen Y, Dekker JH. Effect of pelvic floor muscle training compared with watchful waiting in older women with symptomatic mild pelvic organ prolapse: randomised controlled trial in primary care. BMJ. 2014;349.
    1. Bø K, Anglès-Acedo S, Batra A, Brækken IH, Chan YL, Jorge CH, et al. International urogynecology consultation Chap. 3 committee 2; Conservative treatment of patient with pelvic organ prolapse: pelvic floor muscle training. Int Urogynecol J. 2022;33(10):2633–67. - PubMed - PMC - DOI

LinkOut - more resources